Relative Strength Chart ALK-Abelló A/S

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 14/07/2026 BST			5-day change	1st Jan Change
240.40 ^DKK	0.00%		-0.25%	+5.16%

06-15	ALK Receives UK Approval For EURneffy 1 Mg As The First And Only Needle-Free Adrenaline Treatment For Young Children At Risk Of Anaphylaxis	CI
06-15	UK Regulator OKs Lower Dose of ALK-Abelló's Severe Allergic Reaction Treatment	MT

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ALK-ABELLÓ A/S	Other Pharmaceuticals	0.00%	-0.25%	+5.16%	+22.65%	+61.45%	8.12B